Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Oct 30, 2025 · Filed Nov 3, 2025
The CFO of Calix sold $650K of Calix shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$650,000
Shares × reported transaction price
1 day after results of Oct 29, 2025, 90 days before results of Jan 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.9% | +1.1% | −5.0% |
| 30 days | −18.0% | +1.4% | −19.4% |
| 90 days | −27.7% | +3.0% | −30.7% |
| 180 days | −33.6% | +6.3% | −40.0% |
Past results only. Not a forecast.
Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 17, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.